Form D — Vertical Longevity Pharmaceuticals, Inc.
0002087846-26-000003 · filed Sep 28, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $110,000
- Total sold
- $110,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Vertical Longevity Pharmaceuticals, Inc.
- CIK
- 2087846
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 17 RINCON
IRVINE, CA 92620 - Phone
- 7608558072
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David Philip Scieszka · Executive OfficerIrvine, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗